Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects
US9221781B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 31, 2012 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | Dec 31, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to chromenone compounds of formula (I), pharmaceutically acceptable salts, prodrugs thereof, and the composition comprising the compounds or the like. They can be used to modulating the function of estrogen receptor ER-α36 preventing and/or treating the estrogen related diseases, such as breast cancer, leukemia, liver cancer and etc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.